Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026)
Humacyte's (HUMA) quarterly Interest Coverage Ratio came in at 11.63 in Q2 2026, little changed year-over-year from 11.58 in Q2 2025, and up 8.71% quarter-over-quarter from 12.74 in Q1 2026.
Powered by 
Analysis
Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Interest Coverage Ratio for 7 consecutive years, with 11.63 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio changed 0.42% year-over-year to 11.63 in Q2 2026; TTM through Jun 2026 was 10.8, a 1.8% decrease from a year earlier, with the FY2025 full-year figure at 9.61, up 22.05% from the prior year.
- Interest Coverage Ratio was 11.63 for Q2 2026 at Humacyte, up from 12.74 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.73 in Q1 2025 and troughed at 16.83 in Q3 2023.
- A 5-year average of 12.7 and a median of 12.57 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 58.96% in 2022 and tumbled 64.76% in 2026, its largest moves.
- Over 5 years, Interest Coverage Ratio stood at 12.69 in 2022, then dropped by 19.3% to 15.14 in 2023, then advanced by 26.02% to 11.2 in 2024, then grew by 10.99% to 9.97 in 2025, then fell by 16.67% to 11.63 in 2026.
- The last three Interest Coverage Ratio figures came in at 11.63 (Q2 2026), 12.74 (Q1 2026), and 9.97 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.53 Bn | 2.57 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | 2.71 |
| 10 | Humacyte | 133.72 Mn | 133.72 Mn | -825,000.00 | -11.63 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.63 |
| Mar 31, 2026 | -12.74 |
| Dec 31, 2025 | -9.97 |
| Sep 30, 2025 | -9.34 |
| Jun 30, 2025 | -11.68 |
| Mar 31, 2025 | -7.73 |
| Dec 31, 2024 | -11.20 |
| Sep 30, 2024 | -12.40 |
| Jun 30, 2024 | -11.73 |
| Mar 31, 2024 | -14.65 |
| Dec 31, 2023 | -15.14 |
| Sep 30, 2023 | -16.83 |
| Jun 30, 2023 | -15.63 |
| Mar 31, 2023 | -13.25 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -14.32 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -15.22 |
| Dec 31, 2021 | -15.48 |
| Sep 30, 2021 | -17.06 |